Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes

Translational Research

Volumn 161, Issue 1, 2013, Pages 1-14

  Giudicessi, John R ^a   Ackerman, Michael J ^b,c  

^a MAYO CLINIC   (United States)

^b Windland Smith Rice Sudden Death Genomics Laboratory   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; BRUGADA SYNDROME; CLINICAL PRACTICE; DNA MODIFICATION; DNA POLYMORPHISM; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; GENE EXPRESSION; GENETIC VARIABILITY; HEART ARRHYTHMIA; HEART DISEASE; HEART HEMODYNAMICS; HERITABLE CARDIAC ARRHYTHMIA SYNDROME; HUMAN; LONG QT SYNDROME; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; REVIEW; SHORT QT SYNDROME; ST SEGMENT ELEVATION;

EID: 84870933622     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2012.08.005     Document Type: Review

References (83)

1. M. Cerrone, and S.G. Priori Genetics of sudden death: focus on inherited channelopathies Eur Heart J 32 2011 2109 2118
2. J.R. Giudicessi, and M.J. Ackerman Potassium-channel mutations and cardiac arrhythmias-diagnosis and therapy Nat Rev Cardiol 9 2012 319 332
3. S.G. Priori, C. Napolitano, and P.J. Schwartz Low penetrance in the long-QT syndrome: clinical impact Circulation 99 1999 529 533
4. B.P. Scicluna, A.A. Wilde, and C.R. Bezzina The primary arrhythmia syndromes: same mutation, different manifestations. Are we starting to understand why? J Cardiovasc Electrophysiol 19 2008 445 452
5. H. Morita, J. Wu, and D.P. Zipes The QT syndromes: long and short Lancet 372 2008 750 763
6. C. Antzelevitch Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes Am J Physiol Heart Circ Physiol 293 2007 H2024 H2038
7. C. Patel, G.X. Yan, and C. Antzelevitch Short QT syndrome: from bench to bedside Circ Arrhythm Electrophysiol 3 2010 401 408
8. C. Antzelevitch, and G.X. Yan J wave syndromes Heart Rhythm 7 2010 549 558
9. S.G. Priori, C. Napolitano, and N. Tiso Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196 200
10. H. Lahat, E. Pras, and T. Olender A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel Am J Hum Genet 69 2001 1378 1384
11. S.G. Priori, and S.R. Chen Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis Circ Res 108 2011 871 883
12. Y. Ruan, N. Liu, and S.G. Priori Sodium channel mutations and arrhythmias Nat Rev Cardiol 6 2009 337 348
13. L. Venetucci, M. Denegri, C. Napolitano, and S.G. Priori Inherited calcium channelopathies in the pathophysiology of arrhythmias Nat Rev Cardiol 2012 [Epub ahead of print].
14. G.M. Vincent, K.W. Timothy, M. Leppert, and M. Keating The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome N Engl J Med 327 1992 846 852
15. M.T. Viadero, E. Rubin, T. Amigo, and D. Gonzalez-Lamuno Three generations of hereditary long-QT syndrome with complete penetrance caused by the p.G316E KCNQ1 mutation Pediatr Cardiol 32 2011 102 104
16. K.E. Berge, K.H. Haugaa, A. Fruh, and O.G. Anfinsen Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers Scand J Clin Lab Invest 68 2008 362 368
17. A.M. Lahtinen, A. Marjamaa, H. Swan, and K. Kontula KCNE1 D85N polymorphism-a sex-specific modifier in type 1 long QT syndrome? BMC Med Genet 12 2011 11
18. S.G. Priori, C. Napolitano, and M. Gasparini Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families Circulation 102 2000 2509 2515
19. A.V. Postma, I. Denjoy, and J. Kamblock Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients J Med Genet 42 2005 863 870
20. C. van der Werf, I. Nederend, and N. Hofman Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives Circ Arrhythm Electrophysiol 5 4 2012 748 756
21. A.O. Grant, M.P. Carboni, and V. Neplioueva Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation J Clin Invest 110 2002 1201 1209
22. S.G. Priori, C. Napolitano, P.J. Schwartz, R. Bloise, L. Crotti, and E. Ronchetti The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge Circulation 102 2000 945 947
23. J. Wei, D.W. Wang, and M. Alings Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel Circulation 99 1999 3165 3171
24. C. Bezzina, M.W. Veldkamp, and M.P. van Den Berg A single Na(+) channel mutation causing both long-QT and Brugada syndromes Circ Res 85 1999 1206 1213
25. N. Makita, E. Behr, and W. Shimizu The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome J Clin Invest 118 2008 2219 2229
26. W. Zareba, A.J. Moss, and E.H. Locati Modulating effects of age and gender on the clinical course of long QT syndrome by genotype J Am Coll Cardiol 42 2003 103 109
27. S.G. Priori, P.J. Schwartz, and C. Napolitano Risk stratification in the long-QT syndrome N Engl J Med 348 2003 1866 1874
28. A.K. Gehi, T.D. Duong, L.D. Metz, J.A. Gomes, and D. Mehta Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis J Cardiovasc Electrophysiol 17 2006 577 583
29. M. Yokokawa, T. Noda, and H. Okamura Comparison of long-term follow-up of electrocardiographic features in Brugada syndrome between the SCN5A-positive probands and the SCN5A-negative probands Am J Cardiol 100 2007 649 655
30. T. Kubota, W. Shimizu, S. Kamakura, and M. Horie Hypokalemia-induced long QT syndrome with an underlying novel missense mutation in S4-S5 linker of KCNQ1 J Cardiovasc Electrophysiol 11 2000 1048 1054
31. C. Napolitano, P.J. Schwartz, and A.M. Brown Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias J Cardiovasc Electrophysiol 11 2000 691 696
32. P. Yang, H. Kanki, and B. Drolet Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes Circulation 105 2002 1943 1948
33. R. Dumaine, J.A. Towbin, and P. Brugada Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent Circ Res 85 1999 803 809
34. P.M. Rautaharju, B. Surawicz, and L.S. Gettes AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology J Am Coll Cardiol 53 2009 982 991
35. N.W. Taggart, C.M. Haglund, D.J. Tester, and M.J. Ackerman Diagnostic miscues in congenital long-QT syndrome Circulation 115 2007 2613 2620
36. Y. Hong, P.M. Rautaharju, and P.N. Hopkins Familial aggregation of QT-interval variability in a general population: results from the NHLBI Family Heart Study Clin Genet 59 2001 171 177
37. C. Newton-Cheh, M.G. Larson, and D.C. Corey QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: the Framingham Heart Study Heart Rhythm 2 2005 277 284
38. E.L. Akylbekova, R.S. Crow, and W.D. Johnson Clinical correlates and heritability of QT interval duration in blacks: the Jackson Heart Study Circ Arrhythm Electrophysiol 2 2009 427 432
39. A.J. Sauer, and C. Newton-Cheh Clinical and genetic determinants of torsade de pointes risk Circulation 125 2012 1684 1694
40. I. Splawski, J. Shen, and K.W. Timothy Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 Circulation 102 2000 1178 1185
41. A. Marjamaa, V. Salomaa, and C. Newton-Cheh High prevalence of four long QT syndrome founder mutations in the Finnish population Ann Med 41 2009 234 240
42. L. Refsgaard, A.G. Holst, G. Sadjadieh, S. Haunso, J.B. Nielsen, and M.S. Olesen High prevalence of genetic variants previously associated with LQT syndrome in new exome data Eur J Hum Genet 20 8 2012 905 908
43. E.G. Schouten, J.M. Dekker, P. Meppelink, F.J. Kok, J.P. Vandenbroucke, and J. Pool QT interval prolongation predicts cardiovascular mortality in an apparently healthy population Circulation 84 1991 1516 1523
44. H. Elming, E. Holm, and L. Jun The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens Eur Heart J 19 1998 1391 1400
45. M.C. de Bruyne, A.W. Hoes, J.A. Kors, A. Hofman, J.H. van Bemmel, and D.E. Grobbee Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study Eur Heart J 20 1999 278 284
46. E. Pietila, H. Fodstad, and E. Niskasaari Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women J Am Coll Cardiol 40 2002 511 514
47. C.R. Bezzina, A.O. Verkerk, and A. Busjahn A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization Cardiovasc Res 59 2003 27 36
48. L. Gouas, V. Nicaud, and M. Berthet Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population Eur J Hum Genet 13 2005 1213 1222
49. A. Pfeufer, S. Jalilzadeh, and S. Perz Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study Circ Res 96 2005 693 701
50. C. Newton-Cheh, C.Y. Guo, and M.G. Larson Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study Circulation 116 2007 1128 1136
51. J. Koskela, J. Laiho, and M. KaHonen Potassium channel KCNH2 K897T polymorphism and cardiac repolarization during exercise test: the Finnish Cardiovascular Study Scand J Clin Lab Invest 68 2008 31 38
52. A. Aydin, S. Bahring, and S. Dahm Single nucleotide polymorphism map of five long-QT genes J Mol Med (Berl) 83 2005 159 165
53. I. Splawski, K.W. Timothy, and M. Tateyama Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia Science 297 2002 1333 1336
54. A. Burke, W. Creighton, and E. Mont Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks Circulation 112 2005 798 802
55. S. Chen, M.K. Chung, D. Martin, R. Rozich, P.J. Tchou, and Q. Wang SNP S1103Y in the cardiac sodium channel gene SCN5A is associated with cardiac arrhythmias and sudden death in a white family J Med Genet 39 2002 913 915
56. D.E. Arking, A. Pfeufer, and W. Post A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization Nat Genet 38 2006 644 651
57. A.J. Aarnoudse, C. Newton-Cheh, and P.I. de Bakker Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study Circulation 116 2007 10 16
58. C. Newton-Cheh, M. Eijgelsheim, and K.M. Rice Common variants at ten loci influence QT interval duration in the QTGEN Study Nat Genet 41 2009 399 406
59. A. Pfeufer, S. Sanna, and D.E. Arking Common variants at ten loci modulate the QT interval duration in the QTSCD Study Nat Genet 41 2009 407 414
60. P.J. Schwartz, S.G. Priori, and C. Napolitano How really rare are rare diseases?: the intriguing case of independent compound mutations in the long QT syndrome J Cardiovasc Electrophysiol 14 2003 1120 1121
61. P. Westenskow, I. Splawski, K.W. Timothy, M.T. Keating, and M.C. Sanguinetti Compound mutations: a common cause of severe long-QT syndrome Circulation 109 2004 1834 1841
62. L. Crotti, A.L. Lundquist, and R. Insolia KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome Circulation 112 2005 1251 1258
63. Y. Nishio, T. Makiyama, and H. Itoh D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome J Am Coll Cardiol 54 2009 812 819
64. S. Kaab, D.C. Crawford, and M.F. Sinner A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes Circ Cardiovasc Genet 5 2012 91 99
65. L. Hein, J.D. Altman, and B.K. Kobilka Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission Nature 402 1999 181 184
66. D.A. Mason, J.D. Moore, S.A. Green, and S.B. Liggett A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor J Biol Chem 274 1999 12670 12674
67. K.J. Paavonen, H. Swan, and K. Piippo Beta1-adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome Int J Cardiol 118 2007 197 202
68. P.J. Schwartz, E. Vanoli, and L. Crotti Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome J Am Coll Cardiol 51 2008 920 929
69. L. Crotti, M.C. Monti, and R. Insolia NOS1AP is a genetic modifier of the long-QT syndrome Circulation 120 2009 1657 1663
70. M. Tomas, C. Napolitano, and L. De Giuli Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome J Am Coll Cardiol 55 2010 2745 2752
71. K. Chen, and N. Rajewsky Natural selection on human microRNA binding sites inferred from SNP data Nat Genet 38 2006 1452 1456
72. P. Saetrom, J. Biesinger, and S.M. Li A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis Cancer Res 69 2009 7459 7465
73. D. Landi, F. Gemignani, and A. Naccarati Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer Carcinogenesis 29 2008 579 584
74. L.J. Chin, E. Ratner, and S. Leng A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk Cancer Res 68 2008 8535 8540
75. Z. Tan, G. Randall, and J. Fan Allele-specific targeting of microRNAs to HLA-G and risk of asthma Am J Hum Genet 81 2007 829 834
76. B. Conne, A. Stutz, and J.D. Vassalli The 3' untranslated region of messenger RNA: a molecular 'hotspot' for pathology? Nat Med 6 2000 637 641
77. N.H. Gehring, U. Frede, and G. Neu-Yilik Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia Nat Genet 28 2001 389 392
78. M. Kelly, R.D. Bagnall, and R.E. Peverill A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia J Mol Cell Cardiol 51 2011 848 854
79. A.S. Amin, J.R. Giudicessi, and A.J. Tijsen Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner Eur Heart J 33 2012 714 723
80. J.K. Park, L.J. Martin, X. Zhang, A.G. Jegga, and D.W. Benson Genetic variants in SCN5A promoter are associated with arrhythmia phenotype severity in patients with heterozygous loss-of-function mutation Heart Rhythm 9 2012 1090 1096
81. P. Yang, T.T. Koopmann, and A. Pfeufer Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activity Eur J Hum Genet 16 2008 350 357
82. J.W. Mason, D.J. Ramseth, D.O. Chanter, T.E. Moon, D.B. Goodman, and B. Mendzelevski Electrocardiographic reference ranges derived from 79,743 ambulatory subjects J Electrocardiol 40 2007 228 234
83. M.H. Gollob, C.J. Redpath, and J.D. Roberts The short QT syndrome: proposed diagnostic criteria J Am Coll Cardiol 57 2011 802 812